Signal2026-06-11
ClinicalTrials.gov

[PHASE1] Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

Part of

Advances In Cancer Treatment Protocols

Open primary sourceSee the whole picture